News Sentiment

TYRA sentiment intelligence

Tyra Biosciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 60 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 32.75 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+7.0% over one week, +21.3% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Price to earnings forward of Tyra Biosciences, Inc. – NASDAQ:TYRA

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 7.0% Price confirming higher
Trend fit Trend inactive 21.3% over four weeks
Fair value 78.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 34
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
TradingView 8
TradingKey 5
PR Newswire 5
Moomoo 4
simplywall.st 4
www.marketscreener.com 3
Stock Titan 3

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 13
Analyst action 10
Guidance 3
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 60
Moomoo Direct company coverage

Barclays Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $59

Barclays analyst Eliana Merle has reiterated a Buy rating for TYRA BIOSCIENCES, INC. (TYRA.US) and maintained a target price of $59. According to TipRanks, Merle has a 36.8% success rate and a 1.4% average return over the past year. This rating indicates a continued positive outl

Tone
Positive 74/100
Event
Analyst action
Published
08 Jun 2026 12:10
Source
Moomoo